Critical Success Factors In the Implementation of Strategy by the Multinational Corporations in the Pharmaceutical Industry: An Empirical Investigation

Authors

  • Zachary Bolo Awino

DOI:

https://doi.org/10.14738/abr.42.1919

Abstract

Strategy implementation is the key that opens doors to creatively align organizational strategy with its internal support systems that transforms analyzed and formulated strategies into action. An organization in the pharmaceutical business, which is a business that competes in the knowledge economy for discovering and commercializing therapeutic agents, must endeavour to continually develop strategies to protect its intellectual capital and improve performance.  Despite this realisation the importance of strategy implementation, is still greatly overshadowed by a focus on the strategy formulation process. Literature available on strategy implementation is very scarce and especially in the pharmaceutical industry. This study, therefore, is poised to explore and determine the critical success factors for strategy implementation among Multinational corporations in the Kenyan pharmaceutical industry. The study was conducted in Kenya in 2014 as a census survey of twelve Multinational pharmaceutical corporations. Data for this survey was collected through the use of structured questionnaires, which were distributed to 36 respondents of which 32 responded an 89% respondent rate. This study was hinged on the dynamics capabilities theory, resource based view theory and the concept of competitive advantage. Data analysis was done using descriptive statistics and factor analysis to a large extent. Results indicate that critical success factors for strategy implementation include; Infrastructure factors; Clear and concise communication of the strategy to the staff, with a variance loading of(0.942)Resource set aside for new strategy,(0.871,variance loading),Planning, co-ordinating, monitoring and delegation of responsibilities for implementation of strategy,(0.970), Organisational structure  that is supportive(0.889).Time frame; Specified time frame allocated for strategy implementation(0.971), allocation for obstacles surfaced during implementation that were not envisioned beforehand, environmental factors also emerged as key to this process. For competitive advantage. People-product mix; Possession of detailed knowledge on customers' needs, tastes and preferences by employees, hiring and retraining top talent within the organization, continuous product improvement and innovations, Production of unique products for a specific target market, partnering with customers to produce highly customized products and strategic alliances with key stakeholders in the industry. These factors had implication on theory and practice since they were found to be universal.

References

Al

Global UNIDO Project; strengthening the local production of essential generic drugs in least developed and developing countries, Vienna 2010.

Gassmann. O. Reepmeyer. G, Von Zedtwitz, M (2004b) Leading Pharmaceutical Innovation Trends and Drivers for Growth in the Pharmaceutical Industry, Berlin: Springer.

Gorsuch, R. L. (1983), NJ: Lawrence Erlbaum Associates. Factor analysis (2nd Ed.). Hillsdale,

Ireri, K.M, (2013),” Factors Affecting Strategy Implementation Process; The Pharmaceutical Distributors within Nairobi County” Unpublished MBA Research Project University of Nairobi.

Johnson, G., Scholes, K. and Whittington, R. (2005) Exploring corporate strategy: text and cases, (7th Edition), Prentice Hall.

Kosiom, C.J (2013),” The challenges of Implementing Global Strategies by Multinational Organizations in Kenya”, Unpublished MBA Research Project University Nairobi.

Li, Y, Guohui, S. Eppler M.J. (2008) Making Strategy Work: A Literature Review Factors influencing strategy implementation. ICA working paper.

Mbithi, M.N, (2011),” Strategy implementation at Nakumatt holdings Limited, Kenya”, Unpublished MBA Research Project University of Nairobi.

Mugenda O.M & Mugenda A.G (2003), Research Methods: Quantitative and qualitative appproch ACTS Press Nairobi, Kenya.

Nyaboke, R.O, (2012),” Strategies applied by Multinational Pharmaceutical MBA Corporations in Kenya to attainable sustainable Competitive Advantage”Unpublished Research Project University of Nairobi

Porter, M, (1990), The Competitive Advantage of Nations, THE FREE PRESS, A Division McMillan, Inc., New York, 1990, p xii.

Porter, M. E. (1985). Competitive Advantage; Creating and Sustaining Superior Performance. New York: The Free Press.

Porter, M. (1980), Competitive Strategy, New York, Free Press Pearce, J.A & Robinson, R.B., (2010) Strategic Management: Formulation, Implementation and Control, (12th Intl Edition).

Peteraf, M. (1993).The cornerstones of competitive advantage: A resource

Prahalad, C. K., & Hamel, G. (1990). the core competence of the corporation.

Harvard.Business Review, 68, 3: 79<91. Quinn. J. B. (1992). Intelligent enterprise. New York, NY: Free Press.

Rajan. V.P & Jayachandran, S., (1999). Marketing Strategy: An Assessment of the State of the Filed and Outlook. Journal of the Academy of Marketing Science 27 (2): 120<143.

Sapienza, A. M. (1995).Managing scientists: Leadership strategies in research and development. New York, NY: Wiley

Saloner, G., Shepard, A., & Podolny J, (2001).Strategic Management, New York: John Wiley & Sons.

Slater, S F, and Naver, J. C. (1995). Market orientation and the learning organization. Journal of Marketing, 59.

Thompson, Strickland, Gamble (2007), Crafting and executing a strategy, edition Irwin, McGraw Hill Boston U.S.A.

UNIDO (2010).Pharmaceutical sector profile: Kenya. Retrieve from http://www.unido.org/.../Kenya_Pharma%20Sector%20profile_TEGLO050

Weihnrich, H. and Kootzn, H. (1993). Management: A Global Perspective (10th Ed.)McGraw Hill.

Downloads

Published

2016-03-31

How to Cite

Awino, Z. B. (2016). Critical Success Factors In the Implementation of Strategy by the Multinational Corporations in the Pharmaceutical Industry: An Empirical Investigation. Archives of Business Research, 4(2), 58–72. https://doi.org/10.14738/abr.42.1919